Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

KIT is required for hepatic function during mouse post-natal development.

Laetitia Magnol1, Marie-Clémence Chevallier, Valérie Nalesso

  • 1Institut de Transgénose, TAAM, UPS44, IEM UMR6218, CNRS, Université Orléans, Orléans, France. magnol@cnrs-orleans.fr <magnol@cnrs-orleans.fr>

BMC Developmental Biology
|July 7, 2007
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Standardized Pipeline for Metabolism and Cognition in GO-DS21 Mouse Model: Investigating Down Syndrome Comorbidities.

Current protocols·2026
Same author

SEARCHING FOR NEW GENES THAT CAUSE USHER SYNDROME.

American journal of ophthalmology·2026
Same author

A Deep-Red-Absorbing Osmium(II) Complex as a Photosensitizer for Photodynamic Therapy Inducing Immunogenic Cell Death.

Angewandte Chemie (International ed. in English)·2026
Same author

Correction to "Three in One: <i>In Vitro</i> and <i>In Vivo</i> Evaluation of Anticancer Activity of a Theranostic Agent that Combines Magnetic Resonance Imaging, Optical Bioimaging, and Photodynamic Therapy Capabilities".

ACS applied bio materials·2026
Same author

Inflammatory and resolution stages of hepatic injury: imaging with USPIO-enhanced MRI in mice.

European radiology experimental·2026
Same author

Aminoadipate-semialdehyde synthase, a potential target for substrate reduction therapy in glutaric aciduria type 1.

Scientific reports·2026
Same journal

Dexamethasone priming enhances stemness and immunomodulatory property of tissue-specific human mesenchymal stem cells.

BMC developmental biology·2021
Same journal

Comparative transcriptome analysis uncovers cell wall reorganization and repressed cell division during cotton fiber initiation.

BMC developmental biology·2021
Same journal

Msx1 haploinsufficiency modifies the Pax9-deficient cardiovascular phenotype.

BMC developmental biology·2021
Same journal

Identification of reference genes for gene expression studies among different developmental stages of murine hearts.

BMC developmental biology·2021
Same journal

The miR-200 family in normal mammary gland development.

BMC developmental biology·2021
Same journal

Development of the indirect flight muscles of Aedes aegypti, a main arbovirus vector.

BMC developmental biology·2021
See all related articles
This summary is machine-generated.

Kit mutations cause juvenile steatosis in mice by disrupting lipid metabolism genes in the liver, impacting neonatal growth and survival. This highlights Kit's role in liver development and neonatal health.

Area of Science:

  • Molecular Biology
  • Developmental Biology
  • Genetics

Background:

  • The Kit gene encodes a receptor tyrosine kinase crucial for melanogenesis, hematopoiesis, and gametogenesis.
  • Kit mutations lead to diverse phenotypes, from coat color changes to embryonic lethality.
  • Intermediate hypomorphic mutations can cause growth retardation and post-natal mortality.

Purpose of the Study:

  • Investigate the post-natal role of Kit using chemically-induced hypomorphic mutations in mice.
  • Determine the impact of Kit loss-of-function on neonatal development and metabolism.

Main Methods:

  • Utilized a panel of chemically-induced hypomorphic Kit mutations in mice.
  • Analyzed post-natal phenotypes, focusing on liver and lipid metabolism.
  • Examined gene expression related to triglyceride metabolism.

Related Experiment Videos

Main Results:

  • Kit mutations induced juvenile steatosis, a condition of fat accumulation in the liver.
  • Observed downregulation of VldlR, Lpin1, and Lpl genes involved in lipid metabolism.
  • Kit loss-of-function mimicked inactivation of triglyceride metabolism genes, causing neonatal growth and viability defects.

Conclusions:

  • This study is the first to link KIT to neonatal lipid metabolism and juvenile steatosis.
  • Reinforces Kit's essential role in liver development.
  • Suggests caution when using KIT inhibitors in anti-cancer treatments due to potential developmental impacts.